126 related articles for article (PubMed ID: 2178869)
1. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
Rai G; Wright G; Scott L; Beston B; Rest J; Exton-Smith AN
Curr Med Res Opin; 1990; 11(10):638-47. PubMed ID: 2178869
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
[TBL] [Abstract][Full Text] [Related]
3. Acetyl-L-carnitine for dementia.
Hudson S; Tabet N
Cochrane Database Syst Rev; 2003; 2003(2):CD003158. PubMed ID: 12804452
[TBL] [Abstract][Full Text] [Related]
4. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease.
Thal LJ; Carta A; Clarke WR; Ferris SH; Friedland RP; Petersen RC; Pettegrew JW; Pfeiffer E; Raskind MA; Sano M; Tuszynski MH; Woolson RF
Neurology; 1996 Sep; 47(3):705-11. PubMed ID: 8797468
[TBL] [Abstract][Full Text] [Related]
5. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M
Neurology; 1991 Nov; 41(11):1726-32. PubMed ID: 1944900
[TBL] [Abstract][Full Text] [Related]
6. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.
Pettegrew JW; Klunk WE; Panchalingam K; Kanfer JN; McClure RJ
Neurobiol Aging; 1995; 16(1):1-4. PubMed ID: 7723928
[TBL] [Abstract][Full Text] [Related]
7. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
Herrmann WM; Dietrich B; Hiersemenzel R
Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
[TBL] [Abstract][Full Text] [Related]
8. L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
Goety CG; Tanner CM; Cohen JA; Thelen JA; Carroll VS; Klawans HL; Fariello RG
Mov Disord; 1990; 5(3):263-5. PubMed ID: 2143808
[No Abstract] [Full Text] [Related]
9. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.
Sano M; Bell K; Cote L; Dooneief G; Lawton A; Legler L; Marder K; Naini A; Stern Y; Mayeux R
Arch Neurol; 1992 Nov; 49(11):1137-41. PubMed ID: 1444880
[TBL] [Abstract][Full Text] [Related]
10. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.
Thal LJ; Calvani M; Amato A; Carta A
Neurology; 2000 Sep; 55(6):805-10. PubMed ID: 10994000
[TBL] [Abstract][Full Text] [Related]
11. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
[TBL] [Abstract][Full Text] [Related]
12. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
Acierno G
Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
[No Abstract] [Full Text] [Related]
13. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.
Montgomery SA; Thal LJ; Amrein R
Int Clin Psychopharmacol; 2003 Mar; 18(2):61-71. PubMed ID: 12598816
[TBL] [Abstract][Full Text] [Related]
15. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
Bonavita E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
[TBL] [Abstract][Full Text] [Related]
16. Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency.
Arrigo A; Casale R; Buonocore M; Ciano C
Int J Clin Pharmacol Res; 1990; 10(1-2):133-7. PubMed ID: 2387660
[TBL] [Abstract][Full Text] [Related]
17. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
Cipolli C; Chiari G
Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia.
Lenzi A; Sgrò P; Salacone P; Paoli D; Gilio B; Lombardo F; Santulli M; Agarwal A; Gandini L
Fertil Steril; 2004 Jun; 81(6):1578-84. PubMed ID: 15193480
[TBL] [Abstract][Full Text] [Related]
19. Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type.
Parnetti L; Abate G; Bartorelli L; Cucinotta D; Cuzzupoli M; Maggioni M; Villardita C; Senin U
Drugs Aging; 1993; 3(2):159-64. PubMed ID: 8477148
[TBL] [Abstract][Full Text] [Related]
20. An example of a clinical trial in patients with Alzheimer's disease: some methodological issues.
Lucca U; Menasce G; Comelli M; Cizza G; Bressi S; Frattura L; Tiraboschi P; Spagnoli A
Prog Clin Biol Res; 1989; 317():1301-10. PubMed ID: 2690098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
